Frontiers in Oncology (Jul 2022)

Carbon Ion Radiotherapy Induce Metabolic Inhibition After Functional Imaging-Guided Simultaneous Integrated Boost for Prostate Cancer

  • Yulei Pei,
  • Yulei Pei,
  • Yulei Pei,
  • Renli Ning,
  • Renli Ning,
  • Renli Ning,
  • Wei Hu,
  • Wei Hu,
  • Wei Hu,
  • Ping Li,
  • Ping Li,
  • Ping Li,
  • Zhenshan Zhang,
  • Zhenshan Zhang,
  • Zhenshan Zhang,
  • Yong Deng,
  • Yong Deng,
  • Yong Deng,
  • Zhengshan Hong,
  • Zhengshan Hong,
  • Zhengshan Hong,
  • Yun Sun,
  • Yun Sun,
  • Yun Sun,
  • Xiaomao Guo,
  • Xiaomao Guo,
  • Xiaomao Guo,
  • Qing Zhang,
  • Qing Zhang,
  • Qing Zhang

DOI
https://doi.org/10.3389/fonc.2022.845583
Journal volume & issue
Vol. 12

Abstract

Read online

PurposeAs local recurrence remains a challenge and the advantages of the simultaneous integrated boost (SIB) technique have been validated in photon radiotherapy, we applied the SIB technique to CIRT. The aim was to investigate the metabolomic changes of the CIRT with concurrent androgen deprivation therapy (ADT) in localized prostate cancer (PCa) and the unique metabolic effect of the SIB technique.Material and MethodsThis study enrolled 24 pathologically confirmed PCa patients. All patients went through CIRT with concurrent ADT. The gross target volume (GTV) boost was defined as positive lesions on both 68Ga-PSMA PET/CT and mpMRI images. Urine samples collected before and after CIRT were analyzed by the Q-TOF UPLC-MS/MS system. R platform and MetDNA were used for peak detection and identification. Statistical analysis and metabolic pathway analysis were performed on Metaboanalyst.ResultsThe metabolite profiles were significantly altered after CIRT. The most significantly altered metabolic pathway is PSMA participated alanine, aspartate and glutamate metabolism. Metabolites in this pathway showed a trend to be better suppressed in the SIB group. A total of 11 identified metabolites were significantly discriminative between two groups and all of them were better down-regulated in the SIB group. Meanwhile, among these metabolites, three metabolites in DNA damage and repair related purine metabolism were down-regulated to a greater extent in the SIB group.ConclusionMetabolic dysfunction was one of the typical characteristics of PCa. CIRT with ADT showed a powerful inhibition of PCa metabolism, especially in PSMA participated metabolic pathway. The SIB CIRT showed even better performance on down-regulation of most metabolism than uniform-dose-distribution CIRT. Meanwhile, the SIB CIRT also showed its unique superiority to inhibit purine metabolism. PSMA PET/CT guided SIB CIRT showed its potentials to further benefit PCa patients.

Keywords